Literature DB >> 1725108

Improved expression vectors for eukaryotic promoter/enhancer studies.

J L Fridovich-Keil1, J M Gudas, I B Bryan, A B Pardee.   

Abstract

We describe two transfectable vectors designed to facilitate the functional analysis of eukaryotic promoter/enhancer sequences. The first, pJFCAT1, is an improved chloramphenicol acetyltransferase (CAT) reporter gene expression vector with two features that distinguish it from the majority of other CAT vectors currently in use: 1) it carries a trimer cassette of the simian virus 40 major late polyadenylation site to block plasmid-initiated read-through expression of CAT, and 2) it includes the phage f1 origin of replication, permitting generation of single-stranded copies to serve as templates for oligonucleotide-directed mutagenesis or single-strand DNA sequencing. The promoterless pJFCAT1 directs little if any CAT activity in transfected mouse L cells and, therefore, may be particularly useful for the analysis of weak promoters whose activity is otherwise masked by background CAT expression. The second vector, pTAG-1, uses human beta-globin as a reporter gene and was designed to facilitate the analysis of reporter gene expression at the RNA level. Like pJFCAT1, pTAG-1 also includes the simian virus 40 polyadenylation site trimer cassette located just upstream of the promoter insertion site. We have used each of these vectors to study functional elements in the human and mouse thymidine kinase promoters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725108

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  12 in total

1.  Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

Authors:  A L Gartel; X Ye; E Goufman; P Shianov; N Hay; F Najmabadi; A L Tyner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Dysregulated surface gene expression from disrupted hepatitis B virus genomes.

Authors:  Z M Huang; T S Yen
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

3.  PAX8-mediated activation of the wt1 tumor suppressor gene.

Authors:  M Dehbi; J Pelletier
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

4.  Cloning and characterization of the 5' end and promoter region of the chicken acetyl-CoA carboxylase gene.

Authors:  C El Khadir-Mounier; N Le Fur; R S Powell; C Diot; P Langlois; J Mallard; M Douaire
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

5.  Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-beta and C/EBP-delta and their activation by phosphorylation.

Authors:  A Ray; B K Ray
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  3'-untranslated sequences mediate post-transcriptional regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA by 25-hydroxycholesterol.

Authors:  J W Choi; D M Peffley
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

7.  Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm.

Authors:  Z M Huang; T S Yen
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region.

Authors:  E Pikarsky; H Sharir; E Ben-Shushan; Y Bergman
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells.

Authors:  E Ben-Shushan; H Sharir; E Pikarsky; Y Bergman
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Analysis of the promoter element of the serum amyloid A gene and its interaction with constitutive and inducible nuclear factors from rabbit liver.

Authors:  A Ray; B K Ray
Journal:  Gene Expr       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.